Category Archives: compounding
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction.
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019 — Lawley Pharmaceuticals today announced AndroFeme 1, … Continue reading
Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address
In 2015 Comment in the prestigious medical journal Lancet Diabetes & Endocrinology by two of the world’s leading female sexual health specialists, Prof. … Continue reading
On Monday 15th July 2019 in a comprehensive interview on the Life Matters program (ABC Radio National) two of Australia’s premier menopause specialists, Dr Elizabeth Farrell and … Continue reading
MEDIA RELEASE 3rd August 2017 A recent Federal Court case highlights the very real risk and cost to Compounding Pharmacies who do not … Continue reading